Showing 1 - 20 results of 85,004 for search '(( c marked increase ) OR ((( a ((we decrease) OR (nn decrease)) ) OR ( a marked increase ))))', query time: 0.76s Refine Results
  1. 1

    ALS patients’ tissues exhibit increased phosphorylation of MARK2. by Yu-Ning Lu (10291271)

    Published 2021
    “…<p>(<b>A</b>) Representative immunoblot analyses of PKCδ, MARK2-<sup>595</sup>T, and eIF2α in the spinal cord tissues from ALS patients and non-ALS controls, indicating that increased phosphorylation of PKCδ-<sup>505</sup>T, MARK2-<sup>595</sup>T, and eIF2α-<sup>51</sup>S is a general phenotype in patient tissues. …”
  2. 2

    Deletion of Hhp2 markedly increased Sre1 activity. by Hao Miao (1742044)

    Published 2020
    “…<p>Deletion of <i>hhp2</i><sup>+</sup> gene markedly increased Sre1 activity in the presence/absence of CLZ (2 μg/ml to 8 μg/ml) (A), TER (2 μg/ml to 8 μg/ml) (B) or CoCl<sub>2</sub> (0.08 mM to 0.32 mM) (C). …”
  3. 3
  4. 4

    Increased phosphorylation of MARK2 occurs in the affected tissues of a mutant SOD1-induced ALS mouse model. by Yu-Ning Lu (10291271)

    Published 2021
    “…The staining of phosphorylated MARK2-<sup>595</sup>T in all 3 brain regions is increased in the SOD1<sup>G93A</sup> mice as compared to NTg mice. …”
  5. 5

    Long-range chromosomal interactions increase and mark repressed gene expression during adipogenesis by Kristina M. Garske (11220178)

    Published 2022
    “…In summary, we identify LRIs that mark repressed regions of the genome, and these interactions increase across adipogenesis, pinpointing developmental regions that need to be repressed in a cell-type specific way for adipogenesis to proceed.…”
  6. 6

    Withdrawal of Type I JAKinibs increased STAT phosphorylation, a phenomenon present but markedly lower in Type II JAKinibs. by Ilya Gurevic (1326786)

    Published 2025
    “…(A) pJAK2 peaked at time zero after exposure to baricitinib and ruxolitinib and then decreases. …”
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    The Transition from a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk by Heba M Ismail (9568748)

    Published 2022
    “…Conclusions</p> <p>A transition from an increase to a decrease in AUC C-peptide approximately 1.5 years pre-diagnosis was validated in two independent cohorts. …”
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20